YK Bioventures
InvestorActiveYK Bioventures is a venture capital firm founded in 2023 and headquartered in Burlingame, California. Co-founded by Mitchell Kossar and Gary Yeung, the firm invests in healthcare and biotechnology companies across the United States, with a focus on drug discovery, life sciences, and related sectors. As of Sep 2026, the firm has deployed capital across at least 16 investments, including co-leading the $70M Series B round for Moonwalk Biosciences in September 2026. YK Bioventures has raised multiple funds under the 'Opportunities Fund' series; its third fund (YK Bioventures Opportunities Fund III) was open as of June 2026, while Fund II is listed as closed.
Founder Intel
Sign in to read intel from founders who have worked with YK Bioventures.
What founders say about YK Bioventures
Be the first to share intel on YK Bioventures — it's free.
Get Started FreeRelated on The List
- 2048 Ventures — Investor · New York, NY, United States
- 4BIO Capital — Investor · London, United Kingdom
- 8VC — Investor · Austin, TX, USA
- AbbVie Ventures — Investor · Cambridge, MA, United States
- Adeline Arts & Science — Investor · London, United Kingdom
Comparing options? Founders discuss fundraising in the forum, or browse the rest of The List.